We analyze the main upstream regulators of CBX3 expression and activity and describe the various pathways involving CBX3, highlighting its differential mechanisms of action as well as its significance as a potential therapeutic biomarker in lung cancer. This evidence concerns the gene CBX3 and lung carcinoma.